Mitochondria-derived peptides in aging and healthspan

Area of Science:

• Mitochondrial biology and aging research.

Background:

• Mitochondrial dysfunction is central to aging and healthspan.
• Microproteins, including mitochondria-derived peptides (MDPs), have been an unexplored area.
• Eight MDPs, such as humanin and MOTS-c, are currently identified.

Purpose of the Study:

• To review recent advances in microprotein discovery, focusing on MDPs.
• To discuss the role of MDPs in aging.
• To explore the implications of MDPs for understanding and treating age-related diseases.

Main Methods:

• Review of current literature on microproteins and MDPs.
• Analysis of the known functions and implications of identified MDPs.
• Discussion of potential applications in genomics, proteomics, and drug development.

Main Results:

• MDPs represent a novel class of biologically active molecules encoded within mitochondrial DNA.
• Emerging evidence links specific MDPs to key aging processes.
• MDPs have potential roles in type 2 diabetes, cancer, and neurodegenerative diseases.

Conclusions:

• MDPs are a significant area for future research in aging and age-related diseases.
• Understanding MDPs can provide new therapeutic targets.
• This field holds promise for advancing genomic, proteomic, and drug-development strategies.